John Lanzafame, CFO of CSCS, is an entrepreneurial, operations-focused senior executive with extensive experience in building and leading organizations. Leveraging over twenty years in the medical device industry combined with years of technology and sports management, Mr. Lanzafame combines extensive experience in business development and executive-level management with a strong technical background in product development and commercialization.
He has negotiated dozens of technology licenses between diverse entities including Fortune 50 companies and leading government research laboratories and universities, and he has leveraged these transactions to generate substantial value from novel technologies in the healthcare field. Mr. Lanzafame has led product development organizations for a diverse range of products, ranging from Class 3 to Class 1 medical devices and pharmaceutical formulations for novel oncology treatments.
Mr. Lanzafame has served in a variety of leading positions in both public and private companies, including as President of MyoCardioCare, Inc., a private medical device company; CEO of Biophan Technologies, Inc., a public medical technology development company; and President of STS Biopolymers, Inc., a private OEM company that developed high performance polymer coatings for the medical device industry, including lubricious coatings for catheters and guidewires and drug eluting coatings for stents and central catheters. He has also served on the boards of directors of several private and public companies.
Mr. Lanzafame also writes for the website www.ProPlayerInsiders.com, a website partnered with the NFL Players Association providing positive, player-centered stories from the National Football League.
Mr. Lanzafame holds a bachelor’s degree in chemical engineering from the University of Dayton and a master’s degree in industrial engineering management from Rochester Institute of Technology.